R
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
Price:
10 810
HUF
1.6%
Market Closed
Market Cap:
Ft2T
Relative Value
The Relative Value of one RICHTER stock under the Base Case scenario is 32 615.48 HUF. Compared to the current market price of 10 810 HUF, Richter Gedeon Vegyeszeti Gyar Nyrt is Undervalued by 67%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RICHTER
Relative Value
Base Case
32 615.48
HUF
Undervaluation 67%
R
Multiples Across Competitors
RICHTER Competitors Multiples
Richter Gedeon Vegyeszeti Gyar Nyrt Competitors
Richter Gedeon Vegyeszeti Gyar Nyrt Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HU |
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
|
1.9T HUF | 2.2 | 8.5 | 5.5 | 6.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 17.4 | 56.1 | 37.6 | 40.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
560.6B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
287.9B CHF | 4.7 | 30.7 | 12.9 | 15.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.3B GBP | 5.1 | 31.6 | 15.1 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.3B USD | 4.6 | 15.6 | 11 | 13 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.6B CHF | 5.3 | 20.5 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13.1 | 9.2 | 10.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
148.6B USD | 2.4 | 15.4 | 7.8 | 10.6 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.8 | 8.3 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
